Med Ed Is'Rotten,' Says Outspoken Doc on a Quest for Reform Med Ed Is'Rotten,' Says Outspoken Doc on a Quest for Reform
From financial conflicts of interest to exploitive licensing practices, Bryan Carmody is outraged at med ed practices harming young docs. His scorched-earth response has won him fans and critics.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 4, 2021 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

' Exciting': Olaparib Benefit Also in Early BRCA+ Breast Cancer'Exciting': Olaparib Benefit Also in Early BRCA+ Breast Cancer
Patients taking olaparib had a 42% reduction in the risk of local recurrence of breast cancer, metastatic recurrence of breast cancer, other new cancers, or death due to any cause.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 4, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Continued R & D into Alzheimer ’s disease means hope for patients, families and caregivers
More than 6 million Americans, most of them age 65 or older, live with Alzheimer ’s disease, a devastating degenerative brain disease and the most common form of dementia. After heart disease and cancer, Alzheimer’s disease is thethird leading cause of death for seniors, responsible for one out of every three deaths. Not only do patients need an effective treatment and cure, but the health care system does, too. Alzheimer ’s burden isexpected to cost the nation more than $1.1 trillion by 2050. (Source: The Catalyst)
Source: The Catalyst - June 4, 2021 Category: Pharmaceuticals Authors: Richard Moscicki, M.D. Tags: Research and Development Alzheimer's Source Type: news

Roche presents data on giredestrant, a next generation selective oestrogen receptor degrader for people with hormone receptor-positive, HER-2 negative breast cancer
Basel, 4 June 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the presentation of new and updated data on giredestrant (formerly known as GDC-9545), an investigational next generation oral selective oestrogen receptor degrader (SERD), in people with hormone receptor (HR)-positive, HER2-negative breast cancer. Breast cancer is now the most common cancer in the world, with HR-positive being the most common subtype representing 70% of cases.1,2 Data from these studies will be presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held June 4-8, 2021.“We’re encour...
Source: Roche Investor Update - June 4, 2021 Category: Pharmaceuticals Source Type: news

Targeted Radiotherapy Might Help Men Battling Advanced Prostate Cancer
FRIDAY, June 4, 2021 -- Patients with advanced prostate cancers may have newfound hope: Researchers identified a new potential treatment for men with metastatic castration-resistant prostate cancer, which has no cure. Metastatic castration-resistant... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 4, 2021 Category: General Medicine Source Type: news

Drug Lynparza Could Help Fight Some Early-Stage Breast Cancers
FRIDAY, June 4, 2021 -- A twice-daily pill can dramatically reduce the risk of breast cancer recurrence in women who are genetically prone to the disease, researchers report. The pill — olaparib (Lynparza) — works by blocking a natural enzyme... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 4, 2021 Category: General Medicine Source Type: news

Breast cancer drug hope for women with Angelina gene
SCIENTISTS have had a major breakthrough in the treatment of early breast cancer for women carrying a BRCA mutation - dubbed the "Angelina Jolie gene". (Source: Daily Express - Health)
Source: Daily Express - Health - June 4, 2021 Category: Consumer Health News Source Type: news

Drug Lynparza Could Help Fight Some Early-Stage Breast Cancers
Title: Drug Lynparza Could Help Fight Some Early-Stage Breast CancersCategory: Health NewsCreated: 6/4/2021 12:00:00 AMLast Editorial Review: 6/4/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - June 4, 2021 Category: Cancer & Oncology Source Type: news

Targeted Radiotherapy Might Help Men Battling Advanced Prostate Cancer
Title: Targeted Radiotherapy Might Help Men Battling Advanced Prostate CancerCategory: Health NewsCreated: 6/4/2021 12:00:00 AMLast Editorial Review: 6/4/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - June 4, 2021 Category: Cancer & Oncology Source Type: news

What Is Usually the First Sign of Ovarian Cancer
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 4, 2021 Category: General Medicine Source Type: news

Can You Prevent Prostate Cancer
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 4, 2021 Category: General Medicine Source Type: news

First Phase Results of MYLUNG Consortium Provide Historical View of Biomarker Testing Patterns and Identify Data Gaps for Ongoing Prospective Research
Over 80 percent of non-small cell lung cancer detected at Stage 4Fewer than 50 percent of patients had five or more biomarker testsMedian time from diagnosis to first-line therapy is about five weeks (Source: McKesson News)
Source: McKesson News - June 4, 2021 Category: Information Technology Source Type: news

High BMI linked to higher risk of interval breast cancer
Women who had a higher body-mass index (BMI) had a greater likelihood of a...Read more on AuntMinnie.comRelated Reading: Cancer screening may still be valuable for older individuals PET/MRI advances efforts for virtual biopsy in breast cancer COVID-19 widens disparities in breast screening Does digital mammography fall short for surveillance imaging? AI, radiomics can predict cancer in lesions found on breast MRI (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 4, 2021 Category: Radiology Source Type: news

New drug effective against lung cancers caused by common genetic error
(NYU Langone Health / NYU Grossman School of Medicine) A new drug reduced tumor size in patients who have lung cancer patients with a specific, disease-causing change in the gene KRAS, a study found. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 4, 2021 Category: Cancer & Oncology Source Type: news

Colorectal Cancer: UVA Health Expert Helps Develop New National Screening Guidelines
(University of Virginia Health System) Most Americans should get screened for colorectal cancer beginning at age 45 instead of age 50, according to new recommendations from the U.S. Preventive Services Task Force, which includes UVA Health's Li Li, MD, PhD, MPH. This recommendation applies to Americans without symptoms who do not have a history of colorectal polyps or a personal or family health history of genetic disorders that increase the risk of colorectal cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 4, 2021 Category: Cancer & Oncology Source Type: news

Robots with T-ray technology to spot and remove cancer tumors in £ 8 million project
(University of Warwick) New technology that will marry probes that can detect cancer tumors through the skin with high-precision robotic surgery is to be developed for use in hospital settings for the first time in a project led by the University of Warwick. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 4, 2021 Category: Cancer & Oncology Source Type: news

Newly approved drug effective against lung cancer caused by genetic mutation
(Washington University School of Medicine) The new drug sotorasib reduces tumor size and shows promise in improving survival among patients with lung tumors caused by a specific DNA mutation, according to results of a global phase 2 clinical trial led by Washington University School of Medicine in St. Louis. The drug is designed to shut down the effects of the mutation, which is found in about 13% of patients with lung adenocarcinoma, a common type of non-small-cell lung cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 4, 2021 Category: Cancer & Oncology Source Type: news

Study finds lower mortality rate for men at high risk for death from prostate cancer who received early postoperative radiation therapy
(Brigham and Women's Hospital) A new, retrospective study focuses on men who have both high-grade prostate cancer that extends outside the prostate and/or has spread into the lymph nodes. For these men who are at high risk of dying from the disease, there was a significant reduction in the risk of death with adjuvant radiation therapy (aRT) use, suggesting that it should be offered to these men. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 4, 2021 Category: Cancer & Oncology Source Type: news

Remote patient monitoring may reduce need to hospitalize cancer patients
(Mayo Clinic) A study by researchers at Mayo Clinic Cancer Center has found that cancer patients diagnosed with COVID-19 who received care at home via remote patient monitoring were significantly less likely to require hospitalization for their illness, compared to cancer patients with COVID-19 who did not participate in the program. Results of the study were presented Friday, June 4, at the American Society of Clinical Oncology Annual Meeting and published in the Journal of Clinical Oncology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 4, 2021 Category: International Medicine & Public Health Source Type: news

Collaboration controls killers
(St. Jude Children's Research Hospital) St. Jude immunologists are researching how effector and killer T cells can be controlled to destroy cancer cells that resist treatment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 4, 2021 Category: International Medicine & Public Health Source Type: news

Newly approved targeted therapy sotorasib prolongs survival in KRAS G12C-mutated lung cancer
(University of Texas M. D. Anderson Cancer Center) Results from the Phase II cohort of the CodeBreaK 100 study showed that treatment with the KRAS G12C inhibitor sotorasib achieved a 37.1% objective response rate and 12.5 months median overall survival in previously treated patients with KRAS G12C-mutated non-small cell lung cancer (NSCLC), according to researchers from The University of Texas MD Anderson Cancer Center. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 4, 2021 Category: International Medicine & Public Health Source Type: news

Wide variation in cost and transparency of payer-negotiated prices for thyroid cancer care
(Brigham and Women's Hospital) Since Jan. 1, 2021, hospitals in the US have been required by The Centers for Medicare and Medicaid Services (CMS) to provide pricing information online about items and services. A team of researchers from Brigham and Women's Hospital and Massachusetts Eye and Ear leveraged the newly available data to analyze price transparency and price variation for the treatment of thyroid cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 4, 2021 Category: International Medicine & Public Health Source Type: news

Most US adults may lack knowledge about palliative care
(American Association for Cancer Research) The majority of surveyed Americans had an inadequate understanding of palliative care, and frequency of health care utilization was one determinant of knowledge. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 4, 2021 Category: Cancer & Oncology Source Type: news

Oncotarget: Inflammatory microenvironment & hepatic macrophage in hepatocellular carcinoma
(Impact Journals LLC) " The incidence of hepatocellular carcinoma (HCC) is increasing worldwide, and HCC is amongst the leading causes of cancer death globally. " (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 4, 2021 Category: International Medicine & Public Health Source Type: news

FDA Approves Tembexa (brincidofovir) for the Treatment of Smallpox
DURHAM, N.C., June 04, 2021 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, today announced that the U.S. Food and Drug... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 4, 2021 Category: Drugs & Pharmacology Source Type: news

Groundbreaking Early Cancer Detection Test Studied at Mayo Clinic Introduced Nationally
Mayo Clinic today recognized the debut of a groundbreaking multi-cancer early cancer detection (MCED) test called Galleri? that can detect more than 50 types of cancers[1] through a simple blood draw. The Galleri test is intended  to complement U.S. guideline-recommended cancer screenings. Mayo Clinic Oncologist Minetta Liu, M.D. was involved in the development of the new test. [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - June 4, 2021 Category: Research Source Type: news

Benefit Also in Early Stage: Olaparib in BRCA+ Breast Cancer Benefit Also in Early Stage: Olaparib in BRCA+ Breast Cancer
Patients taking olaparib had a 42% reduction in the risk of local recurrence of breast cancer, metastatic recurrence of breast cancer, other new cancers, or death due to any cause.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 3, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

'Next big wave': Radiation drugs track and kill cancer cells
Doctors are reporting improved survival in men with advanced prostate cancer from an experimental drug that delivers radiation directly to tumor cells (Source: ABC News: Health)
Source: ABC News: Health - June 3, 2021 Category: Consumer Health News Tags: Health Source Type: news

Pill shows benefit in certain hard-to-treat breast cancers
A pill has been shown to help keep certain early-stage, hard-to-treat breast cancers at bay after initial treatment (Source: ABC News: Health)
Source: ABC News: Health - June 3, 2021 Category: Consumer Health News Tags: Health Source Type: news

Practice Halt: No Benefit in Cervical Cancer With Adjuvant Chemo Practice Halt: No Benefit in Cervical Cancer With Adjuvant Chemo
Adjuvant chemotherapy did not improve survival and was associated with significantly higher toxicity.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 3, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Immunotherapy Likely New Standard in Advanced Esophageal Cancer Immunotherapy Likely New Standard in Advanced Esophageal Cancer
Nivolumab with chemotherapy or nivolumab with ipilimumab improved overall survival as compared with standard chemotherapy in advanced ESCC.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 3, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

AstraZeneca and Merck point to progress in fighting breast cancer
Lynparza shown to reduce recurrence rates, while Novartis to unveil new type of radiotherapy (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - June 3, 2021 Category: Pharmaceuticals Source Type: news

AstraZeneca and Merck point to progress on early-stage breast cancer
Lynparza shown to reduce recurrence rates, while Novartis to unveil new type of radiotherapy (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - June 3, 2021 Category: Pharmaceuticals Source Type: news

New Drug Toripalimab Improves Survival in Nasopharyngeal Cancer New Drug Toripalimab Improves Survival in Nasopharyngeal Cancer
Improved survival in a phase 3 trial where the new drug was added onto chemotherapy could move immunotherapy to the first line, say experts.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 3, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Adjuvant Immunotherapy Benefit in Resected Kidney Cancer Adjuvant Immunotherapy Benefit in Resected Kidney Cancer
After surgery, progression-free survival was significantly longer for patients with high-risk renal carcinoma who received immunotherapy with pembrolizumab than for those who received placebo.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 3, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' Major Milestone' in mCRPC: Radiopharmaceutical Boosts Survival'Major Milestone' in mCRPC: Radiopharmaceutical Boosts Survival
A new radiopharmaceutical that targets prostate cancer cells has taken a step closer to the clinic after boosting both progression-free and overall survival.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 3, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Drug may help more women survive hereditary breast cancer
International trials of olaparib were stopped early as benefits of ‘groundbreaking’ drug became clearWomen with hereditary breast cancer, triggered by the BRCA1 or BRCA2 genes, stand a better chance of survival following successful trials of a drug that cuts the likelihood of the cancer returning after treatment.A major trial carried out by academic researchers to see whether olaparib can prevent recurrence was stopped early – after two-and-a-half years instead of the planned 10 years – when the benefits of the drug became clear.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - June 3, 2021 Category: Science Authors: Sarah Boseley Health editor Tags: Science Cancer research Medical research Source Type: news

CRC Screening: 45 Is the New 50, and 85 Is the New 75 CRC Screening: 45 Is the New 50, and 85 Is the New 75
Lowering the recommended age for colorectal cancer screening to 45 and continuing screening for many beyond 75 could save many thousands of lives, experts say.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 3, 2021 Category: Cancer & Oncology Tags: Gastroenterology News Source Type: news

Blue Earth points to Axumin studies at ASCO meeting
Bracco molecular imaging subsidiary Blue Earth Diagnostics announced that severa...Read more on AuntMinnie.comRelated Reading: Blue Earth touts Axumin results in Lancet Blue Earth touts fluciclovine F-18 research at ASCO GU Blue Earth eyes new uses for fluciclovine F-18 Use F-18 fluciclovine PET/MRI to stage prostate cancer Race affects access to prostate cancer PET (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 3, 2021 Category: Radiology Source Type: news

Upstate Cancer Center doctor to present results of clinical trial for small cell lung cancer at American Society of Clinical Oncology Annual Meeting
Evidence shows once daily radiation therapy treatment is effective. (Source: SUNY Upstate Medical)
Source: SUNY Upstate Medical - June 3, 2021 Category: Universities & Medical Training Tags: News Research Source Type: news

Mastocytosis and Hymenoptera Venom Allergy Profiled in the U.S.
Mastocytosis occurs more often among U.S. patients with hymenoptera venom anaphylaxis versus general population (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 3, 2021 Category: Cancer & Oncology Tags: Family Medicine, Internal Medicine, Allergy, Oncology, Journal, Source Type: news

Consider Second Biopsy for Transected Melanomas Consider Second Biopsy for Transected Melanomas
Investigators concluded that a second biopsy should be considered when the first one is transected to ensure surgical and other management decisions are based on an accurate Breslow depth.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 3, 2021 Category: Cancer & Oncology Tags: Dermatology News Source Type: news

Delayed Surgery Tied to Worse Outcome in Lung Cancer Patients Delayed Surgery Tied to Worse Outcome in Lung Cancer Patients
A new study confirms that delayed surgical treatment is associated with poor oncologic outcomes in patients with nonsmall-cell lung cancer.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - June 3, 2021 Category: Surgery Tags: Hematology-Oncology News Source Type: news

Majority of breast cancer patients use complementary therapies
Seventy-three percent of breast cancer patients use complementary therapie...Read more on AuntMinnie.comRelated Reading: Cancer screening may still be valuable for older individuals PET/MRI advances efforts for virtual biopsy in breast cancer COVID-19 widens disparities in breast screening Does digital mammography fall short for surveillance imaging? AI, radiomics can predict cancer in lesions found on breast MRI (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 3, 2021 Category: Radiology Source Type: news

AI-created plan to treat cancer reduced the amount of time patients had to undergo radiation
A study finds that AI-generated cancer treatments may be more efficient and effective than those generated by humans. Still, though, doctors are hesitant to use the AI curated treatments. (Source: the Mail online | Health)
Source: the Mail online | Health - June 3, 2021 Category: Consumer Health News Source Type: news

Choline-PET/CT offers best imaging for hyperparathyroidism
Choline-PET/CT should be the imaging tool of choice for localization of primar...Read more on AuntMinnie.comRelated Reading: PET imaging shows how COVID vaccines confound cancer detection PET promises new approaches in detecting atherosclerosis Choline-PET boosts mpMRI for prostate cancer detection Choline-PET with mpMRI is cost-effective for prostate cancer Novel PET agent targets copper in prostate tumors (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 3, 2021 Category: Radiology Source Type: news

Misconceptions about biking and driving: drivers understanding of Missouri bicycle laws - Grimes A, Subramaniam DP, Lightner J.
Introduction Bicycling has numerous health benefits, such as improvements in cardiorespiratory fitness, and significant risk reductions for cardiovascular disease, cancer, and obesity and has benefits to the environment. However, motorists' behavior has b... (Source: SafetyLit)
Source: SafetyLit - June 3, 2021 Category: International Medicine & Public Health Tags: Jurisprudence, Laws, Legislation, Policies, Rules Source Type: news

Shift work and incidence of psychiatric disorders: the Danish Nurse Cohort study - J ørgensen JT, Rozing MP, Westendorp RGJ, Hansen J, Stayner LT, Simonsen MK, Andersen ZJ.
BACKGROUND: Research on health effects of shift work has especially focused on somatic diseases, such as breast cancer and cardiometabolic disease, while less attention has been given to the association between shift work and mental health. METHODS... (Source: SafetyLit)
Source: SafetyLit - June 3, 2021 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

Bayer-acquires-Noria-and-PSMA-Therapeutics-to-expand-portfolio-in-prostate-cancer
Broadens company’s oncology platform of Targeted Alpha Therapies / Acquisition includes actinium-225 labeled differentiated PSMA small molecule for the treatment of prostate cancer (Source: Bayer Company News)
Source: Bayer Company News - June 3, 2021 Category: Pharmaceuticals Source Type: news

Venetoclax Shows Activity Against T-ALL in Children Venetoclax Shows Activity Against T-ALL in Children
Data from a small retrospective study suggest that venetoclax-based regimens may have activity against relapsed or refractory T-lineage acute lymphoblastic leukemia in children and young adults.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 3, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news